Events Partner Content The 4th Annual Oncolytic Virotherapy Summit - Boston 2018 Join the 4th Oncolytic Virotherapy Summit in Boston
News AZ boasts phase 3 win for self-administered gMG drug Alexion has announced high-level positive results from a phase 3 trial of gefurulimab, a once-weekly self-administered treatment for gMG.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
